$2.60's a nice price, but I don't find it related in any meaningful way with what the price will be when those warrants expire. Absent a collaboration of some form, I think the trial results need to be pretty good and our FDA submissal made in a timely manner in order for the stock to maintain above $2.50 through the end of this year.

What Al does with the LOC if he exercises his warrants will be interesting, that's certainly true. He's been pretty good with his brethren (though diluted) shareholders to date, I expect that to continue.